The University of Iowa

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): A cross sectional study.

Simuni T, Uribe L, Cho RH, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun-Turgut D, Poston K, Poewe W, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman, Marek K, on behalf of the PPMI Investigators.
Lancet Neurology . 2020; 19 (1) 71-80.
PubMed: 
Projects: